微电生理
(688351)
| 流通市值：30.22亿 | | | 总市值：113.89亿 |
| 流通股本：1.25亿 | | | 总股本：4.71亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 336,400,837.87 | 223,748,530.83 | 104,099,813.81 | 413,166,794.49 |
| 营业收入 | 336,400,837.87 | 223,748,530.83 | 104,099,813.81 | 413,166,794.49 |
| 二、营业总成本 | 308,654,820.49 | 201,859,987.04 | 92,572,167.93 | 401,537,623.37 |
| 营业成本 | 137,611,777.99 | 89,276,207.09 | 41,052,440.47 | 170,519,238.94 |
| 税金及附加 | 2,846,155.77 | 2,148,395.43 | 1,023,678.65 | 3,128,777.07 |
| 销售费用 | 95,311,346.03 | 62,936,011.57 | 27,366,770.2 | 110,860,672.58 |
| 管理费用 | 31,323,786.18 | 20,753,359.94 | 11,320,386.3 | 42,638,056.89 |
| 研发费用 | 45,759,833.28 | 30,679,975.05 | 13,417,634.91 | 77,401,893.01 |
| 财务费用 | -4,198,078.76 | -3,933,962.04 | -1,608,742.6 | -3,011,015.12 |
| 其中:利息费用 | 267,626.67 | 181,842.64 | 105,677.23 | 886,734.64 |
| 其中:利息收入 | 3,375,213.61 | 1,999,931.06 | 1,088,047.28 | 4,102,580.22 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 5,576,400 | 3,691,138.89 | 2,560,608.33 | 11,430,173.67 |
| 加:投资收益 | 5,752,496.14 | 4,712,123.65 | 1,807,889.66 | 8,983,819.55 |
| 资产处置收益 | 712,121.36 | 726,244.5 | 726,244.5 | -33,969.45 |
| 资产减值损失(新) | -2,615,676.27 | -1,755,819.94 | -790,521.71 | -2,971,800.66 |
| 信用减值损失(新) | -1,310,636.3 | -49,376.36 | 59,365.67 | -1,270,362.46 |
| 其他收益 | 8,391,284.05 | 5,757,847.08 | 2,041,065.69 | 26,757,938.19 |
| 四、营业利润 | 44,252,006.36 | 34,970,701.61 | 17,932,298.02 | 54,524,969.96 |
| 加:营业外收入 | 9,347.02 | 9,227.03 | - | 23,661 |
| 减:营业外支出 | 2,163,300 | 2,163,300 | 60 | 2,422,759.89 |
| 五、利润总额 | 42,098,053.38 | 32,816,628.64 | 17,932,238.02 | 52,125,871.07 |
| 减:所得税费用 | 177,495.24 | 148,501.38 | 61,743.88 | 55,508.74 |
| 六、净利润 | 41,920,558.14 | 32,668,127.26 | 17,870,494.14 | 52,070,362.33 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 41,920,558.14 | 32,668,127.26 | 17,870,494.14 | 52,070,362.33 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 41,920,558.14 | 32,668,127.26 | 17,870,494.14 | 52,070,362.33 |
| 扣除非经常损益后的净利润 | 24,066,000.8 | 20,806,323.47 | 12,560,308.17 | 5,079,782.38 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.09 | 0.07 | 0.04 | 0.11 |
| (二)稀释每股收益 | 0.09 | 0.07 | 0.04 | 0.11 |
| 八、其他综合收益 | 4,045,296.27 | -18,494.87 | -1,423.97 | 1,450.96 |
| 归属于母公司股东的其他综合收益 | 4,045,296.27 | -18,494.87 | -1,423.97 | 1,450.96 |
| 九、综合收益总额 | 45,965,854.41 | 32,649,632.39 | 17,869,070.17 | 52,071,813.29 |
| 归属于母公司股东的综合收益总额 | 45,965,854.41 | 32,649,632.39 | 17,869,070.17 | 52,071,813.29 |
| 公告日期 | 2025-10-28 | 2025-08-27 | 2025-04-30 | 2025-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |